Guideline on the requirements of external quality assessment programs in molecular pathology

Inter‐laboratory and inter‐observer reproducibility of immunohistochemical assessment of the Ki‐67 labelling index in a large multi‐centre trial

Michael Mengel, Reinhard von Wasielewski, Birgitt Wiese et al. · The Journal of Pathology · 2002 · 214 citations

Medicine, Oncology, Pathology +17

Quality Assurance in Immunohistochemistry

Thomas Rüdiger, Heinz Höfler, Hans Kreipe et al. · The American Journal of Surgical Pathology · 2002 · 102 citations

Medicine, Pathology, Diagnostic Pathology +7

EGFR mutation detection in NSCLC—assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC

Roland Penzel, Christine Sers, Yuan Chen et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2010 · 89 citations

Medicine, Genetics, Oncology +17

External Quality Assessment for <i>KRAS</i> Testing Is Needed: Setup of a European Program and Report of the First Joined Regional Quality Assessment Rounds

Ellen Bellon, Marjolijn J. L. Ligtenberg, Sabine Tejpar et al. · The Oncologist · 2011 · 83 citations · Full text

Medicine, Oncology, Pathology +14

EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy

Erik Thunnissen, Judith V.M.G. Bovée, Hans Bruinsma et al. · Journal of Clinical Pathology · 2011 · 33 citations · Full text

Medicine, Oncology, Pathology +17